Adaptango Performance PRocess for Older Adults Community reHabilitation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEmory University
About this trial
This study is being done to answer the question: How do people with Parkinson's disease, people with Mild Cognitive Impairment, and younger people process difficult topics in conversation? It will also explore themes related to dance, such as community building and justice, as perceived by persons with Parkinson's disease or Mild Cognitive Impairment, and younger individuals before and after the Adaptango performance process.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Individuals (PWP, younger adults, PLwD) from the greater Atlanta area. Those in the PWP group must be diagnosed by a neurologist specialized in Parkinson's disease.
Score of at least 18 on the Montreal Cognitive Assessment (MoCA). Those who are in the PLwD group must score between 18 and 25 on the MoCA.
Disqualifiers
Acute medical illness requiring hospitalization
Uncontrolled congestive heart failure
History of stroke in the past three years
Inability to perform study procedures
Trial design
Design model
Parallel
Treatments tested in this trial
Adaptango Performance Process (APP) program
Other interventionParticipants will take a three-month, biweekly choreographic process, ending in a weekend performance workshop at Emory University. Tango instructors undergo 13 hours of American Council on Exercise-certified training on Adaptango methods, age-specific functional impairments, and fall detection and prevention. Adaptango modifications were made to the frame and several steps of Argentine tango.
Treatment groups
120 Participants
are divided into 3 treatment groupsGroup A: Healthy adults over 18 and less than 31 yearsExperimental treatment 1 intervention
Group B: Adults with Parkinson's disease (PD) age 50 years and overExperimental treatment 1 intervention
Group C: Adults with mild cognitive impairment (MCI) age 50 years and overExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Participants' Satisfaction of the intervention (Acceptability)
Satisfaction will be assessed post-intervention only with an Exit Questionnaire balanced for gender and race. Participants will rate (extremely easy/very easy) and their overall satisfaction with the intervention. A higher score indicates better satisfaction.
Time frame
Post-intervention at 8 months2
Alternate Uses Task (AUT)
The Alternate Uses Task (AUT) will be used to assess the patient's creativity by asking them to come up with as many alternate uses for an everyday object as possible in two minutes. Results are measured across four subscales: fluency- the number of alternative uses thought of originality - how unusual the uses given are; flexibility - the range of ideas in different categories; and elaboration-the level of detail given to an idea. Higher values in each subscale indicate higher levels of creativity.
Time frame
Baseline, 3 months (during intervention), and 8 months (post-intervention)Secondary outcomes
1
Parkinson's Disease Questionnaire Summary Index (PDQ-39 SI)
The PDQ-39 is a patient-reported, disease-specific questionnaire used to assess health status and quality of life in Parkinson's disease over the preceding month. It consists of 39 items grouped into 8 distinct dimensions: mobility (10 items), activities of daily living (6 items), emotional well-being (6 items), stigma (4 items), social support (3 items), cognition (4 items), communication (3 items), and bodily discomfort (3 items). Each item is scored on a 5-point Likert scale indicating frequency: 0 (never), 1 (occasionally), 2 (sometimes), 3 (often), and 4 (always or cannot do at all). The PDQ-39 Summary Index (PDQ-39 SI) is derived by calculating the mean of the 8 dimension scores. Total index scores range from 0 to 100. Lower scores reflect a better health status/quality of life, while higher scores indicate a greater frequency and severity of health-related difficulties.
Time frame
Baseline, 3 months (during intervention), and 8 months (post-intervention)2
The Movement Disorder Society-Sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
The Movement Disorder Society-Sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS) is a comprehensive 50-question clinical tool used to evaluate both motor and non-motor symptoms, severity, and progression of Parkinson's disease. Each item is scored from 0 (normal) to 4 (severe), with higher summed subscale scores indicating greater disability. \*\*Will you be reporting a paticular part of the scale, or are you reporting all? If so, we will need to entere separate parts with their respective scorings\*\*
Time frame
Baseline, 3 months (during intervention), and 8 months (post-intervention)3
30-second chair stand test
The number of sit-to-stand maneuvers completed in 30 seconds is used to measure leg strength and endurance. A higher score is better.
Time frame
Baseline, 3 months (during intervention), and 8 months (post-intervention)4
Timed Up and Go Simple and Dual tasks (TUG, TUG Cognitive and TUG Manual)
Measures the time it takes to rise from a chair, walk 3 meters, turn around, and return to the chair in the simple condition. In the Cognitive condition, one is required to simultaneously count backward by 3s from a number between 20 and 100; in the Manual condition, one is required to simultaneously pick up a cup of water and carry it while completing the task. A lower score is a better outcome.
Time frame
Baseline, 3 months (during intervention), and 8 months (post-intervention)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Emory University
Lead sponsor
National Endowment for the Arts, United States
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: